This talk will give an overview of the biosimilars market, highlight the relevant EU and US legislation and guidelines for biosimilars, and look at some of the challenges and issues involved in this "generic biologics" market.
Audience:
• In-house lawyers
• Non-UK private practitioners with pharma clients
• Patent attorneys
• Regulatory affairs professionals
• Pharmacovigilance professionals
• Commercial managers
• Compliance managers
Speakers:
Anna Feros, Partner
